Search by Drug Name or NDC

    NDC 12496-0300-01 SUBLOCADE 300 mg/1 Details

    SUBLOCADE 300 mg/1

    SUBLOCADE is a SUBCUTANEOUS SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Indivior Inc.. The primary component is BUPRENORPHINE.

    Product Information

    NDC 12496-0300
    Product ID 12496-0300_73ae82ca-2145-481f-9787-eef712d1b4cc
    Associated GPIs 6520001000E530
    GCN Sequence Number 077999
    GCN Sequence Number Description buprenorphine SOLER SYR 300 MG/1.5 SUBCUT
    HIC3 H3W
    HIC3 Description OPIOID WITHDRAWAL THERAPY AGENTS, OPIOID-TYPE
    GCN 44186
    HICL Sequence Number 023438
    HICL Sequence Number Description BUPRENORPHINE
    Brand/Generic Brand
    Proprietary Name SUBLOCADE
    Proprietary Name Suffix n/a
    Non-Proprietary Name buprenorphine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name BUPRENORPHINE
    Labeler Name Indivior Inc.
    Pharmaceutical Class Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
    DEA Schedule CIII
    Marketing Category NDA
    Application Number NDA209819
    Listing Certified Through 2024-12-31

    Package

    NDC 12496-0300-01 (12496030001)

    NDC Package Code 12496-0300-1
    Billing NDC 12496030001
    Package 1 POUCH in 1 CARTON (12496-0300-1) / 1 SYRINGE in 1 POUCH (12496-0300-2) / 1 SOLUTION in 1 SYRINGE (12496-0300-5)
    Marketing Start Date 2018-02-26
    NDC Exclude Flag N
    Pricing Information N/A